These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9020594)

  • 21. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
    Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
    Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between intravenous infusate colonisation and fluid container hang time.
    Rickard CM; Vannapraseuth B; McGrail MR; Keene LJ; Rambaldo S; Smith CA; Ray-Barruel G
    J Clin Nurs; 2009 Nov; 18(21):3022-8. PubMed ID: 19821874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility.
    den Brok MW; Nuijen B; Harms R; Buluran JN; Harvey MD; Grieshaber CK; Beijnen JH
    J Oncol Pharm Pract; 2005 Mar; 11(1):13-9. PubMed ID: 16460599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on bacteriologic contamination of potassium chloride solution 25% in multidose containers regularly used on hospital wards].
    Schramm G; Bianchi S
    Schweiz Med Wochenschr; 1982 Aug; 112(31-32):1099-100. PubMed ID: 6753141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of beta-lactamase-producing and -nonproducing bacteria in intravenous solutions.
    Hugbo PG; Akpan UE
    DICP; 1989 Mar; 23(3):210-3. PubMed ID: 2497589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical and chemical stability of palonosetron HCl in 4 infusion solutions.
    Trissel LA; Xu QA
    Ann Pharmacother; 2004 Oct; 38(10):1608-11. PubMed ID: 15328393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of contamination from air vents during intravenous fluid administration.
    Useh MF; Mbouda B
    East Afr Med J; 1998 Jun; 75(6):322-6. PubMed ID: 9803611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of vanadium-contaminated commercially available albumin solutions on renal tubular function.
    Heinemann G; Braun S; Overbeck M; Page M; Michel J; Vogt W
    Clin Nephrol; 2000 Jun; 53(6):473-8. PubMed ID: 10879668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of capillary electrophoresis in drug quality assessment of synthetic porcine secretin.
    Moumakwa BA; Crawley CD; Purich E; Edinboro L; Karnes HT
    Biomed Chromatogr; 2005 Jan; 19(1):68-79. PubMed ID: 15372508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma glucose level in elective surgical patients administered with 5% dextrose in 0.45% NaCl in comparison with those receiving lactated Ringer's solution.
    Saringcarinkul A; Kotrawera K
    J Med Assoc Thai; 2009 Sep; 92(9):1178-83. PubMed ID: 19772177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of methicillin in dextrose solutions at alkaline pH.
    Lynn B
    N Engl J Med; 1971 Sep; 285(12):690. PubMed ID: 5563485
    [No Abstract]   [Full Text] [Related]  

  • 34. The growth of micro-organisms in intravenous fluids.
    Garcia-Caballero J; Herruzo-Cabrera H; Vera-Cortes ML; Garcia de Lorenzo A; Vazquez-Encinar A; Garcia-Caballero F; del Rey-Calero J
    J Hosp Infect; 1985 Jun; 6(2):154-7. PubMed ID: 2862189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residues in antibiotic preparations, ii: effect of pH on the nature and level of particulate matter in sodium cephalothin intravenous solutions.
    Rebagay T; DeLuca P
    Am J Hosp Pharm; 1976 May; 33(5):443-8. PubMed ID: 5889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial growth tests in anti-neoplastic injectable solutions.
    Paris I; Paci A; Rey JB; Bourget P
    J Oncol Pharm Pract; 2005 Mar; 11(1):7-12. PubMed ID: 16460598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous dextrose for rehydration of elderly patients--an evidence-based review.
    Turner T; Cassano AM
    BMC Geriatr; 2004 Apr; 4():2. PubMed ID: 15086959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions.
    Maki DG; Martin WT
    J Infect Dis; 1975 Mar; 131(3):267-72. PubMed ID: 236343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.